| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107416 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 05/19/2005 | US20050107406 Angiogenesis inhibitors |
| 05/19/2005 | US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions |
| 05/19/2005 | US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107336 Aryl boronic acids for treating obesity |
| 05/19/2005 | US20050107331 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 05/19/2005 | US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease |
| 05/19/2005 | US20050107309 Lowering elevated post-prandial blood glucose levels by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity; insulinotropic effects are enhanced |
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050107292 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 05/19/2005 | US20050107253 Adsorbent for phosphoric acid |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106276 Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof |
| 05/19/2005 | US20050106272 Co-beadlet of dha and rosemary and methods of use |
| 05/19/2005 | US20050106234 Calcium formate for use as a dietary supplement |
| 05/19/2005 | US20050106217 Adjust fatty acid oxidation; stimulating carnitine palmitoyl transferase |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106195 N-octanoyl amino acid composition for slimming the human body |
| 05/19/2005 | US20050106186 Percutaneous preparations |
| 05/19/2005 | US20050106154 GASP1: a follistatin domain containing protein |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106126 Compositions including ammonia oxidizing bacteria and methods of using same |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2551056A1 Benzo[b][1,4]dioxepine derivatives |
| 05/19/2005 | CA2544965A1 Heat moisture treated starch for the treatment of hypoglycaemia |
| 05/19/2005 | CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 05/19/2005 | CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents |
| 05/19/2005 | CA2543643A1 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 05/19/2005 | CA2543611A1 Methods of lowering lipid levels in a mammal |
| 05/18/2005 | EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530559A1 Method and device for producing formic acid formates and use of said formates |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 05/18/2005 | EP1326502B1 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1259484B1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 05/18/2005 | EP1224195B1 C-aryl glucoside sglt2 inhibitors |
| 05/18/2005 | EP1207156B1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/18/2005 | EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1617743A New pharmaceutical combinations for nos inhibitors |
| 05/18/2005 | CN1617737A Compositions and method for normalizing lipid levels in mammalian tissues |
| 05/18/2005 | CN1617729A Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia |
| 05/18/2005 | CN1617728A Antidiabetic formulation and method |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1617717A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1617702A Product containing an extract of red algae of the genus porphyra and methods for protecting cells |
| 05/18/2005 | CN1617676A Method of fattening poultry |
| 05/18/2005 | CN1617670A Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 05/18/2005 | CN1616459A Adenosine derivatives |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616445A Method for synthesizing saturated fatty acid vitamin C ester |
| 05/18/2005 | CN1616427A New method for preparing medicine mitiglinide for treating diabetes |
| 05/18/2005 | CN1616422A Disulfide derivatives useful for treating allergic diseases |
| 05/18/2005 | CN1616079A Chinese medicine for fat reducing and long life |
| 05/18/2005 | CN1616076A Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation |
| 05/18/2005 | CN1616060A Chinese medicine drippling pill preparation for promoting blood circulation and removing blood stasis, promoting Qi circulation and rilieving pain |
| 05/18/2005 | CN1616030A Use of compound preparation in treating human hepatitis, cancer, diabetes and uremia |
| 05/18/2005 | CN1616016A Medicine for treating diabetes and its preparing method |
| 05/18/2005 | CN1616014A Chinese medicine composition for treating diabetes and its preparing method |
| 05/18/2005 | CN1616010A Medicine for treating diabetes and its preparing method |
| 05/18/2005 | CN1616009A Chinese medicine for treating high viscosity blood syndrome and its preparing method |
| 05/18/2005 | CN1616000A Medicine for treating hyper lipidemia and its preparing method |
| 05/18/2005 | CN1615995A Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 05/18/2005 | CN1615983A Diabetes capsule and its recipe |
| 05/18/2005 | CN1615976A Ginkgo leaf and olive leaf health powder and its preparing method |
| 05/18/2005 | CN1615961A Concentratend liuweidihuang lozenge and its preparing method |
| 05/18/2005 | CN1615939A Chinese medicine prescription for breating diabetes retina pathologic change |
| 05/18/2005 | CN1615931A Anqi preparation |
| 05/18/2005 | CN1615926A Red sage root biological oral liquor |
| 05/18/2005 | CN1615915A Medicine for treating diabetes |
| 05/18/2005 | CN1615909A Method for preparing water soluble pearl calcium liquor and powder and-the use for lactolin drink |
| 05/18/2005 | CN1615906A 18 compound amino acid injection and its preparing method |
| 05/18/2005 | CN1615900A New use of nerve mesonium U2 receptor excitomotor rutin |